Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, BLK

Association of Black Cardiologists Creates COVID-19 FAQ Community Watch


WASHINGTON, May 18, 2020 /PRNewswire/ -- Today, the Association of Black Cardiologists (ABC) issued patient-centered frequently asked questions (FAQ Community Watch) related to COVID-19 for its community health advocates and partners. The ABC created FAQ Community Watch to provide concrete and trustworthy information about the danger and challenges of the disease with particular attention to those with heart disease. ABC Community Programs Committee Co-chairs Paul Underwood MD, and Daphne Ferdinand PhD, RN, will update the FAQ Community Watch as needed. 

"The unfortunate higher death rates seen in African Americans and other minorities and disadvantaged persons is not new, but has been magnified by the COVID-19 pandemic and requires urgent, comprehensive action," said Dr. Ferdinand. "Direct, culturally-sensitive messages are needed to inform and motivate the African American community and overcome myths and misinformation."

FAQ Community Watch comprises a set of three separate documents that include a community-facing version of ABC's healthcare professional-oriented COVID-19 FAQ Watch with "COVID-19 Community Guidelines," and "Common Myths and Misconceptions Regarding COVID-19." In addition to informing community members about the medical impact of the coronavirus infection, the Association seeks to raise awareness and encourage action within diverse populations. This is consistent with the Association's focus on traditionally underrepresented communities, particularly African Americans with heart disease.  

LaPrincess Brewer, MD, MPH, Mayo Clinic cardiologist and Community Programs Committee member said, "The ABC has always been a beacon for addressing health inequities directly impacting the African American community and other communities of color. These communities are more accepting of health messaging from those they trust. Thus, our efforts are crucial to help mitigate the unacceptable disparities in COVID-19 cases and outcomes among our most vulnerable populations."

COVID-19 has had a devastating effect on the African American community and those with heart disease, including high blood pressure, diabetes and heart failure, who are at the highest risk of severe infection. FAQ Community Watch addresses critical questions, including what factors put communities of color at increased risk, and what can be done to diminish the spread of COVID-19 and reduce their risk of deadly outcomes.

ABC continues to be inspired by how medical, scientific and spiritual communities are pulling together at the individual, leadership and public health levels to minimize the impact of this pandemic. This collection of downloadable FAQs and accompanying educational resources are available on the ABC website and integrate with earlier actions initiated in response to the virus.

About ABC
Founded in 1974, the ABC is a nonprofit organization dedicated to eliminating the disparities related to cardiovascular disease and achieving health equity such that all people can live long, healthy lives. Membership is open to all interested in the care of people with or at risk for cardiovascular disease, including health professionals, lay members of the community (Community Health Advocates), corporate and institutional members. For more information, visit www.abcardio.org and connect with ABC on Twitter, Facebook, Instagram and LinkedIn

 

SOURCE Association of Black Cardiologists


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: